ATE494282T1 - 2-ethansulfonsäuresalz aus n- hydroxy-4-ä5-ä4-(5- isopropyl-2-methyl-1,3-thiazol-4- yl)phenoxyüpentoxyü benzamidin, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit - Google Patents

2-ethansulfonsäuresalz aus n- hydroxy-4-ä5-ä4-(5- isopropyl-2-methyl-1,3-thiazol-4- yl)phenoxyüpentoxyü benzamidin, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit

Info

Publication number
ATE494282T1
ATE494282T1 AT08741489T AT08741489T ATE494282T1 AT E494282 T1 ATE494282 T1 AT E494282T1 AT 08741489 T AT08741489 T AT 08741489T AT 08741489 T AT08741489 T AT 08741489T AT E494282 T1 ATE494282 T1 AT E494282T1
Authority
AT
Austria
Prior art keywords
benzamidine
thiazol
isopropyl
hydroxy
methyl
Prior art date
Application number
AT08741489T
Other languages
English (en)
Inventor
Jin Soo Lee
Soon Ki Cho
Seoung Kyoo Sung
Young Goo Jin
Jae Hoon Park
Bo Kyung Kim
Ja Hyun Cha
Eun Hee Cho
Jei Man Ryu
Original Assignee
Dong Wha Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Wha Pharm Co Ltd filed Critical Dong Wha Pharm Co Ltd
Application granted granted Critical
Publication of ATE494282T1 publication Critical patent/ATE494282T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
AT08741489T 2007-04-19 2008-04-21 2-ethansulfonsäuresalz aus n- hydroxy-4-ä5-ä4-(5- isopropyl-2-methyl-1,3-thiazol-4- yl)phenoxyüpentoxyü benzamidin, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit ATE494282T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20070038395 2007-04-19
PCT/KR2008/002246 WO2008130172A1 (en) 2007-04-19 2008-04-21 N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
ATE494282T1 true ATE494282T1 (de) 2011-01-15

Family

ID=39875653

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08741489T ATE494282T1 (de) 2007-04-19 2008-04-21 2-ethansulfonsäuresalz aus n- hydroxy-4-ä5-ä4-(5- isopropyl-2-methyl-1,3-thiazol-4- yl)phenoxyüpentoxyü benzamidin, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit

Country Status (11)

Country Link
US (1) US8039635B2 (de)
EP (1) EP2146974B1 (de)
JP (1) JP5102849B2 (de)
KR (1) KR101006254B1 (de)
CN (1) CN101652355B (de)
AT (1) ATE494282T1 (de)
CA (1) CA2684582C (de)
DE (1) DE602008004337D1 (de)
ES (1) ES2355013T3 (de)
MX (1) MX2009010339A (de)
WO (1) WO2008130172A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4657297B2 (ja) * 2004-07-05 2011-03-23 ドン ファ ファーマシューティカル カンパニー リミテッド アレルギー性炎症疾患の予防及び治療用組成物
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100454767B1 (ko) 2001-07-19 2004-11-03 동화약품공업주식회사 4-[(4-티아졸릴)페녹시]알콕시-벤즈아미딘 유도체의골다공증 예방 및 치료제로서의 용도
JP4657297B2 (ja) * 2004-07-05 2011-03-23 ドン ファ ファーマシューティカル カンパニー リミテッド アレルギー性炎症疾患の予防及び治療用組成物
CA2572897C (en) * 2004-07-05 2010-08-24 Dong Wha Pharmaceutical Ind. Co., Ltd. Pharmaceutical composition for the treatment of bone fracture
EP1701722B1 (de) * 2004-11-23 2009-10-14 Dong Wha Pharmaceutical Co., Ltd. N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidin 2 methansulfonsauresalz

Also Published As

Publication number Publication date
US8039635B2 (en) 2011-10-18
EP2146974A1 (de) 2010-01-27
CN101652355A (zh) 2010-02-17
KR20080094634A (ko) 2008-10-23
US20100113538A1 (en) 2010-05-06
WO2008130172A1 (en) 2008-10-30
CN101652355B (zh) 2012-11-07
DE602008004337D1 (de) 2011-02-17
KR101006254B1 (ko) 2011-01-06
JP5102849B2 (ja) 2012-12-19
EP2146974B1 (de) 2011-01-05
MX2009010339A (es) 2009-10-16
EP2146974A4 (de) 2010-04-07
CA2684582A1 (en) 2008-10-30
JP2010521524A (ja) 2010-06-24
CA2684582C (en) 2012-05-29
ES2355013T3 (es) 2011-03-22

Similar Documents

Publication Publication Date Title
JP2017160233A5 (de)
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
BRPI0514386B8 (pt) bis (metanossulfonato) de n-hidróxi-4-{5-[4-(5-isopropil-2-metil-1,3-triazol-4-il)fenóxi]pentóxi}benzamidina, método para preparar os mesmos, suas composições farmacêuticas e formulações orais
NO20084853L (no) Forbindelser som er agonister av muscarinreseptorer og som kan vaere effektive i behandling av smerte, Alzheimers sykdom og/eller schizofreni
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
WO2005021519A3 (en) 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory airway diseases
WO2007032028A8 (en) Thiazolinones and oxazolinones and their use as ptp1b inhibitors
DE60317562D1 (de) Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon
WO2007014290A3 (en) Fungicidal carboxamides
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085004L (no) Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler
DE602004022036D1 (de) Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen
ATE537826T1 (de) Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung
HRP20120867T1 (hr) Selurampanel
CY1111022T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
WO2009153285A3 (en) 1,2-benzisothiazole compounds useful for combating animal pests
CY1111256T1 (el) Παραγωγα αζαδικυκλοοκταν-3-ονης και χρηση τους
EP2042494A4 (de) 2,4,5-trisubstituierte thiazolverbindungen, herstellungsverfahren, pharmazeutische zusammensetzungen und medizinische anwendungen davon
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
WO2007068473A3 (en) Organic compounds
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
ATE494282T1 (de) 2-ethansulfonsäuresalz aus n- hydroxy-4-ä5-ä4-(5- isopropyl-2-methyl-1,3-thiazol-4- yl)phenoxyüpentoxyü benzamidin, verfahren zu seiner herstellung und pharmazeutische zusammensetzung damit
WO2008023003A8 (de) Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
NO20083508L (no) Nye enantiomerisk rene beta-agonister, deres fremstillingsmate og deres anvendelse som medikamenter
ATE451367T1 (de) Verfahren zur herstellung von ziprasidon

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties